Latest Cash Flow News

Careteq Limited faces a significant repayment demand from the ATO over R&D tax claims but is mounting a formal objection backed by legal counsel.

Aroa Biosurgery has reported FY25 results that exceed revenue guidance and deliver a positive normalised EBITDA, setting the stage for ambitious growth and reimbursement expansion in FY26.

Aroa Biosurgery has reported a robust 23% revenue increase in FY25, achieving profitability and positive cash flow, setting the stage for continued growth in FY26.

Develop has initiated significant underground and surface infrastructure works at its Sulphur Springs zinc-copper project in Western Australia, setting the stage for an updated feasibility study and de-risking the project’s development.

Meeka Metals reports strong drilling results at Turnberry Central, extending the Stage 1 oxide open pit by up to 200 metres south and suggesting a significant boost to gold reserves and production plans.

St Barbara’s Concept Study confirms a 3 Mtpa processing hub in Nova Scotia, integrating Cochrane Hill with existing deposits to deliver stable, long-life gold production and strong economics while significantly reducing environmental impact.

Champion Iron Limited reported record quarterly sales and strong earnings in FY2025 Q4, while advancing its DRPF project on schedule and declaring its eighth consecutive dividend.

Korab Resources has extended the completion date for the sale of its Geolsec mineral lease, securing higher royalty rates in the process. This move reshapes the financial terms of a key transaction tied to its Northern Territory phosphate project.

UOA Development Bhd reported a striking surge in first quarter 2025 revenue and profit, driven by strong sales and ongoing project progress. The company’s robust unbilled sales pipeline signals sustained growth ahead.

Top Shelf International Holdings has resolved its long-standing excise debt issue, leading to the dismissal of Australian Taxation Office proceedings against its subsidiary.

CAQ Holdings Limited has successfully restructured its debt repayment schedule and secured a new RMB 6 million loan facility, positioning itself to support operational growth amid efforts to increase occupancy rates.

Fisher & Paykel Healthcare has announced an ordinary dividend of NZD 0.28235294 per share for the six months ending March 31, 2025, payable on July 4. The dividend is unfranked and includes a supplementary component, with a 15% withholding tax applied.